GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Policy Acquisition Expense

IM Cannabis (XCNQ:IMCC) Policy Acquisition Expense


View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


IM Cannabis (XCNQ:IMCC) Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.